PCM, CCM, EOM. The number of reimbursement and quality care program abbreviations can make your head spin. Every practice wants to know how to capture new reimbursements to maintain and further enhance quality care initiatives. Chronic and Principal Care Management (CCM and PCM) help practices get reimbursed for work they already do, with ~1/3 of billable care time coming from existing work. However, success in these programs requires a team approach across staff, physicians, and patients. With the right technology partner, practices can maximize reimbursement from these programs and optimize operations to run multiple reimbursement programs in parallel.
Hawaii Cancer Care has partnered with Canopy, the first Intelligent Care Platform for oncology, to further transform patient outcomes and experiences through continuous care delivery and the implementation of a value-based program, Principal Care Management (PCM).
With a growing need for continuous care delivery, oncology practices are investing more and more resources into remote care without direct reimbursement.
NEW YORK (DATE TBD) —Canopy, the first Intelligent Care Platform for oncology, today announced that Canopy Founder and CEO Lavi Kwiatkowsky was selected as a recipient of the 40 Under 40 in Cancer Award.
New York, New York - Canopy, the first Intelligent Care Platform for oncology, today announced results from a 21-month, real-world study demonstrating that electronic patient-reported outcomes (ePROs) can help identify common side effects in lung cancer patients receiving immunotherapy, both as monotherapy and in combination with chemotherapy. The Identification of key symptomatic differences in patients with shorter duration of therapy could suggest that aggressive early management can extend time on therapy, leading to improved outcomes.
Community oncology practices may see up to a 25% earnings decline in 2023 due in part to the sunset of the Oncology Care Model (OCM), a value-based care program created by CMS and now succeeded by the Enhancing Oncology Model (EOM). There are several key challenges associated with this earnings shift including regulatory changes to drug revenue, increasing costs, and higher standards for outcome-based care. And to add to the complexity, EOM doesn’t start until July 2023, meaning many practices were left with a one-year gap to shoulder patient-care investments and operations with limited or no reimbursement.
.png.avif)
